Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?

Annals of Internal Medicine

Volumn 124, Issue 1 II, 1996, Pages 110-116

  Stern, Michael P ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030046037     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-1_part_2-199601011-00006     Document Type: Conference Paper

References (90)

1. Jarrett RJ. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease - chicken, egg or neither? Diabetologia 1984,26 99-102
2. Jarrett RJ, Shipley MJ. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease - putative association via common antecedents, further evidence from the Whitehall Study. Diabetologia 1988,31 737-40.
3. Hales CN, Barker DJ, Clark PM, Cox U, Fall C, Osmond C, et al. Fetal and infant growth and impaired glucose tolerance at age 64 BMJ. 1991, 303 1019-22
4. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease Lancet. 1989,2.577-80
5. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis Diabetologia 1992,35 595-601
6. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993,36 62-7
7. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP. Birthweight and adult health outcomes in a biethnic population in the USA Diabetologia 1994;37 624-31
8. Reaven GM. Banting lecture 1988 Role of insulin resistance in human disease Diabetes. 1988,37:1595-607.
9. Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ. Early growth and abdominal fatness in adult life J Epidemiol Community Health. 1992,46. 184-6
10. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994,74 761-811
11. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E. et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus Prospective studies of Pima Indians N Engl J Med. 1993:329 1988-92
12. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents Ann Intern Med. 1990,113: 909-15
13. Sicree RA, Zimmet PZ, King HO, Coventry JS. Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr Diabetes. 1987;36 179-36
14. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990,6: 1-27
15. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990,263 2893-8
16. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men Diabetes 1990,39 104-11
17. Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE. Eschwege E. Risk factors for NIDDM in white population. Paris prospective study Diabetes. 1991,40.796-9
18. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects Diabetologia 1993,36 553-9
19. Pell S, D'Alonzo CA. Some aspects of hypertension in diabetes mellitus JAMA 1967,202 104-10.
20. Medalie JH, Papier CM, Goldbourt U, Herman JB. Major factors in the development of diabetes mellitus in 10,000 men Arch Intern Med 1975,135. 811-7
21. Keen H, Jarrett RJ, McCartney P. The ten-year follow-up of the Bedford survey (1962-1972) glucose tolerance and diabetes Diabetologia 1982, 22:73-8
22. Ohlson LO, Larsson B, Svärdsudd K, Welin L, Eriksson H, Wilhelmson L, et al. The influence of body fat distribution on the incidence of diabetes mellitus 13.5 years of follow-up of the participants in the study of men born in 1913 Diabetes 1985,34 1055-8
23. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990,131 443-53
24. Jarrett RJ, Keen H, McCartney P. The Whitehall Study ten year follow-up report on men with impaired glucose tolerance with reference to worsening to diabetes and predictors of death Diabet Med 1984,1 279-83
25. Stern MP, Morales PA, Valdez RA, Monterrosa A, Haffner SM, Mitchell BD, et al. Predicting diabetes Moving beyond impaired glucose tolerance Diabetes 1993;42 706-14.
26. Temple RC, Clark PM, Nagi DK, Schneider AE, Yudkin JS, Hales CN. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics Clin Endocrinol (Oxf) 1990,32:689-93
27. Porte D Jr. Banting lecture 1990. Beta-cells in type II diabetes mellitus Diabetes 1991,40:165-80
28. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, et al. Disproportionately elevated proinsulin in Pima Indians with non-insulin-dependent diabetes mellitus J Clin Endocrinol Metab 1990;70: 1247-53.
29. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus Diabetologia. 1988,31:355-60
30. Haffner SM, Bowsher RR, Mykkänen L, Hazuda HP, Mitchell BD, Valdez RA, et al. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM Diabetes 1994,43 1490-3
31. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians N Engl J Med 1988,319:1500-6
32. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Waldenström J. Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes Diabet Med 1990,7.407-13
33. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance Diabetologia 1984;26 44-9
34. Haffner SM, Miettinen H, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of non-insulin-dependent diabetes mellitus in Mexican Americans Diabetes [In press]
35. Mykkänen L, Kuusisto J, Hales CN, Pyörälä K, Laakso M, Haffner SM. Proinsulin levels are disproportionately increased in elderly prediabetic subjects [Abstract] Diabetologia 1994,37(Suppl 1).A74
36. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY. Proinsulin as a marker for the development of NIDDM in Japanese-American men Diabetes 1995,44.173-9.
37. Berne C, Lithell H, Clark PM, Hales CN. Split proinsulin is an early marker of non-insulin-dependent diabetes mellitus [Abstract]. Diabetologia 1994,7(Suppl 1) A57
38. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis. 1979;32 563-76
39. Society of Actuaries and Association of Life Insurance Medical Directors. Build study, 1979 Chicago Society of Actuaries and Association of Life Insurance Medical Directors; 1980
40. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983,67:968-77.
41. Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death, 13 year follow up of participants in the study of men born in 1913 Br Med J (Clin Res Ed) 1984;288:1401-4
42. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death, a 12 year follow up of participants in the population study of women in Gothenburg, Sweden Br Med J (Clin Res Ed) 1984;289.1257-61.
43. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project J Chronic Dis 1978;31 201-306
44. Keys A, Taylor HL, Blackburn H, Brozek J, Anderson JT, Simonson E. Mortality and coronary heart disease among men studied for 23 years Arch Intern Med 1971,128.201-14
45. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women The Framingham Study Ann Intern Med 1977,87 393-7.
46. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease Four prospective American studies Circulation. 1989,79 8-15
47. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease N Engl J Med. 1980,302 1383-9
48. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution Results from the Framingham Offspring Study Arteriosclerosis 1987;7 483-90.
49. Swinkels DW, Demacker PN, Hendriks JC, van't Laar A. Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals Arteriosclerosis 1989,9 604-13
50. Haffner SM, Mykkänen L, Valdez RA, Paidi M, Stern MP, Howard BV. LDL size and subclass pattern in a biethnic population Arterioscler Thromb 1993;13:1623-30
51. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction JAMA 1988,260 1917-21
52. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992,12 187-95
53. Crouse JR, Parks JS, Schey HM, Kahl FR. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease J Lipid Res 1985,26 566-74
54. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of different density and particle size Atherosclerosis 1992,93:189-99
55. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 1989,320 915-24
56. Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasmmogen activator inhibitor levels in coronary artery disease correlation with age and serum triglyceride concentrations. J Am Coll Cardiol. 1987,9:263-8
57. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels A possible link between insulin resistance and atherothrombosis. Diabetologia 1991,34 457-62
58. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease results from two population studies in Finland Diabetes Care 1979;2:131-41.
59. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population Diabetologia. 1980,19 205-10
60. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations Diabetes Care 1979,2 154-60
61. Welin L, Eriksson H, Larsson B, Ohlson LO, Svärdsudd K, Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men The study of men born in 1913. Diabetologia 1992,35:766-70
62. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as a predictor of coronary heart disease interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial Ann Epidemiol 1994;4 40-5
63. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes, the Rancho Bernardo Study, 1984-1991. Am J Epidemiol 1994;140:857-69
64. Liu QZ, Knowler WC, Nelson RG, Saad MF, Charles MA, Liebow IM, et al. Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses Diabetes 1992,41 1141-50
65. Rewers M, Shetterly SM, Baxter J, Hamman RF. Insulin and cardiovascular disease in Hispanics and non-Hispanic whites (NHW) the San Luis Valley Diabetes Study [Abstract] Circulation 1992,85 865A
66. Stout RW. Insulin and atheroma 20-yr perspective Diabetes Care. 1990, 13:631-54
67. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes Circulation. 1990,81.987-95
68. Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, et al. Coronary heart disease prevalence and its relation to risk factors in American Indians the Strong Heart Study Am J Epidemiol. 1995,142 254-68.
69. Welty TK, Lea ET, Yeh J, Cowan LD, Go O, Fabsitz RR, et al. Cardiovascular disease risk factors among American Indians the Strong Heart Study Am J Epidemiol. 1995,142 269-87
70. McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA. Diabetes, hyperinsulinemia, and coronary risk factors in Bangladeshis in east London. Br Heart J. 1988,60:390-6
71. Chakraborty R, Ferrell RE, Stern MP, Haffner SM, Hazuda HP, Rosenthal M. Relationship of prevalence of non-insulin-dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas Genet Epidemiol 1986,3 435-54
72. Stern MP, Haffner SM. Type II diabetes and its complications in Mexican Americans Diabetes Metab Rev 1990,6 29-45
73. Mitchell BD, Hazuda HP, Haffner SM, Patterson JK, Stern MP. Myocardial infarction in Mexican-Americans and non-Hispanic whites The San Antonio Heart Study. Circulation 1991,83:45-51
74. Stern MP, Bradshaw BS, Eifler CW, Fong DS, Hazuda HP, Rosenthal M. Secular decline in death rates due to ischemic heart disease in Mexican Americans and non-Hispanic whites in Texas, 1970-1980. Circulation 1987; 76:1245-50.
75. Nichaman MZ, Wear ML, Goff DC Jr, Labarthe DR. Hospitalization rates for myocardial infarction among Mexican-Americans and non-Hispanic whites The Corpus Christi Heart Project. Ann Epidemiol 1993,3 42-8
76. Goff DC Jr, Varas C, Ramsey DJ, Wear ML, Labarthe DR, Nichaman MZ. Mortality after hospitalization for myocardial infarction among Mexican Americans and non-Hispanic whites: the Corpus Christi Heart Project. Ethn Dis 1993,3 55-63.
77. Nielsen NV, Ditzel J. Prevalence of macro- and microvascular disease as related to glycosylated hemoglobin in type I and II diabetic subjects An epidemiologic study in Denmark Horm Metab Res Suppl. 1985,15 19-23.
78. Herman JB, Medalie JH, Goldbourt U. Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics Diabetologia 1977;13 229-34
79. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II Associated risk factors Diabetologia 1990,33 542-8
80. Laakso M, Lehto S, Penttilä I, Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes Circulation 1993,88 (Pt 1) 1421-30
81. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation Pathway for lipid oxidation in vivo Proc Natl Acad Sci USA 1993;90.6434-8
82. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dylipidemia of diabetes and renal insufficiency Proc Natl Acad Sci USA 1994;91 9441-5
83. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl J Med. 1993;329 977-86
84. American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes Care. 1993;16:1517-20
85. Jarrett RJ. Why is insulin not a risk factor for coronary heart disease? Diabetologia. 1994;7:945-7.
86. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulineamia, and coronary heart disease Diabetologia. 1994,37:948-52
87. Fontbonne A. Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia. 1994;37:953-5
88. Stern MP. The insulin resistance syndrome: the controvery is dead, long live the controversy! Diabetologia. 1994;37:956-8.
89. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes II. Mortality results. Diabetes 1970;19(Suppl 2).789-830.
90. UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulfonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia. 1983;24:404-11